Jaguar Health (JAGX) Change in Accured Expenses (2014 - 2026)
Jaguar Health (JAGX) reported Change in Accured Expenses of $41000.0 for Q1 2026, down 70.92% year-over-year from $141000.0 in Q1 2025, and up 177.36% quarter-over-quarter from -$53000.0 in Q4 2025.
Jaguar Health (JAGX) Change in Accured Expenses (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Change in Accured Expenses data on file, last reported at $41000.0 in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at $41000.0, down 70.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 million (up 228.6% YoY), and the FY2025 annual result was $2.1 million, up 281.79% from the prior year.
- Change in Accured Expenses rose to $41000.0 in Q1 2026 per JAGX's latest filing, from -$53000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $3.3 million in Q1 2022 and troughed at -$6.7 million in Q3 2023.
- A 5-year average of -$138176.5 and a median of $41000.0 in 2026 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses plunged 5724.0% in 2022, then surged 1017.2% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at -$1.9 million in 2022, then soared by 125.32% to $473000.0 in 2023, then sank by 352.85% to -$1.2 million in 2024, then jumped by 95.57% to -$53000.0 in 2025, then soared by 177.36% to $41000.0 in 2026.
- Business Quant data shows JAGX's Change in Accured Expenses at $41000.0 in Q1 2026, -$53000.0 in Q4 2025, and $528000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 41,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41,000.00 |
| Mar 31, 2026 | 41,000.00 |
| Dec 31, 2025 | -53,000.00 |
| Dec 31, 2025 | -53,000.00 |
| Sep 30, 2025 | 528,000.00 |
| Sep 30, 2025 | 528,000.00 |
| Jun 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 141,000.00 |
| Mar 31, 2025 | 141,000.00 |
| Dec 31, 2024 | -1.20 Mn |
| Dec 31, 2024 | -1.20 Mn |
| Sep 30, 2024 | -309,000.00 |
| Sep 30, 2024 | -309,000.00 |
| Jun 30, 2024 | -157,000.00 |
| Jun 30, 2024 | -157,000.00 |
| Mar 31, 2024 | 531,000.00 |
| Mar 31, 2024 | 531,000.00 |
| Dec 31, 2023 | 473,000.00 |
| Dec 31, 2023 | 473,000.00 |